TG Therapeutics Reports Quadrupled Profit and Raises Sales Forecast
TG Therapeutics (TGTX) reported a fourfold increase in profit compared to the previous year, leading to a stock price spike. The biotech company is developing therapies for B-cell autoimmune diseases with an emphasis on multiple sclerosis treatments.
Tickers: $TGTX